Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2018) 56 P175 | DOI: 10.1530/endoabs.56.P175

ECE2018 Poster Presentations: Calcium and Bone Bone ' Osteoporosis (38 abstracts)

Acromegaly patients with vertebral fractures, have lower trabecular bone score despite no difference in bone mineral density, than non-fractured patients and healthy controls

Martin Kužma 1 , Peter Vaňuga 2 , Ivana Ságová 3 , Dušan Pávai 2 , Peter Jackuliak 1 , Zdenko Killinger 1 , Neil Binkley 4 , Harry Genant 5 & Juraj Payer 1

1Comenius University Faculty of Medicine, 5th Department of Internal Medicine, University Hospital, Bratislava, Slovakia; 2National Institute of Endocrinology and Diabetology, Lubochňa, Slovakia; 3Comenius University Jessenius Faculty of Medicine, 1th Department of Internal Medicine, University Hospital, Martin, Slovakia; 4Department of Medicine, University of Wisconsin, Madison, WI, USA; 5University of California San Francisco, San Francisco, CA, USA.

Introduction: Patients with acromegaly, despite normal or even high bone mineral density (BMD), have prevalent vertebral fractures (VFs). HR-pQCT studies in acromegaly have proposed that impaired trabecular bone microarchitecture possibly plays a role in fragility fracture development. As such, we hypothesized that trabecular bone score (TBS) would be low in patients with acromegaly.

Aim of the study: To compare BMD and TBS in acromegaly patients with and without VFs and healthy controls.

Methods: This cross-sectional study compared patients with acromegaly to age- and BMI-matched healthy controls. Study group was recruited from all acromegaly patients who came to a University Endocrinology clinic for follow-up from 6/2016 – 8/2017 and controls consisting of healthy subjects. In all subjects a single measurement of pituitary axis hormone levels, P1NP,CTx, BMD, (total hip [TH] and lumbar spine [LS]) and trabecular bone score (TBS) was performed. Vertebral fractures were identified by DXA VFA. These images were interpreted by an expert musculoskeletal radiologist (H. Genant) using a semi-quantitative approach.

Results: One-hundred six patients with acromegaly (mean age 56.6 years, mean BMI 30.2 kg/m2) and 104 control subjects (mean age 54.06 years, mean 28.4 BMI kg/m2) were included. There was no difference in TH BMD, CTx and plasma cortisol between study groups. Patients with acromegaly had lower LS BMD (1.002±0.16 vs 1.049±0.15; P<0.05) and TBS (1.19±0.13 vs 1.33±0.14; P<0.0001). higher levels of IGF-1 (244.5±189.2 vs 115.2±37.7 ng/ml; P<0.0001) and P1NP (55.69±34.3 vs 45.47±18.6 ng/l; P<0.05). In total, 13 patients and 4 control subjects had VFs identified using IVA. Among acromegaly patients those with VFs had lower TBS (1.11±0.12 vs 1.20±0.13; P<0.05) and P1NP (32.06±16.9 vs 58.5±34.9 ng/l; P<0.05) levels than non-fractured. No difference in BMD (both measured sites), CTx or IGF-1 was observed.

Conclusions: In this study, acromegaly patients had lower TBS and LS BMD than healthy controls. Additionly, those with VFs had lower TBS, and P1NP, but not BMD (both measured sites) than non-fractured acromegaly subjects. Thus, it could be suggested that VFs in acromegaly subjects are associated with impaired trabecular microarchitecture. We suggest using TBS, rather than BMD, to identify acromegaly patients at high VF risk.

Volume 56

20th European Congress of Endocrinology

Barcelona, Spain
19 May 2018 - 22 May 2018

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.